Pictet Asset Management (UK)’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $180M | Sell |
|
|||||
|
2021
Q1 | $239M | Sell |
|
|||||
|
2020
Q4 | $304M | Buy |
|
|||||
|
2020
Q3 | $208M | Sell |
|
|||||
|
2020
Q2 | $212M | Buy |
|
|||||
|
2020
Q1 | $104M | Buy |
|
|||||
|
2019
Q4 | $89.7M | Sell |
|
|||||
|
2019
Q3 | $90.7M | Sell |
|
|||||
|
2019
Q2 | $210M | Sell |
|
|||||
|
2019
Q1 | $250M | Buy |
|
|||||
|
2018
Q4 | $168K | Buy |
|
|||||
|
2018
Q3 | $235M | Sell |
|
|||||
|
2018
Q2 | $211M | Buy |
|
|||||
|
2018
Q1 | $175M | Buy |
|
|||||
|
2017
Q4 | $158M | Buy |
|
|||||
|
2017
Q3 | $158M | Buy |
|
|||||
|
2017
Q2 | $75.2M | Sell |
|
|||||
|
2017
Q1 | $97.3M | Buy |
|
|||||
|
2016
Q4 | $95.3M | Buy |
|
|||||
|
2016
Q3 | $90.7M | Buy |
|
|||||
|
2016
Q2 | $105M | Buy |
|
|||||
|
2016
Q1 | $47.1M | Buy |
|
|||||
|
2015
Q4 | $63.7M | Sell |
|
|||||
|
2015
Q3 | $56.2M | Buy |
|
|||||
|
2015
Q2 | $69.4M | Buy |
|
|||||
|
2015
Q1 | $42.7M | Buy |
|
|||||
|
2014
Q4 | $42.6M | Buy |
|
|||||
|
2014
Q3 | $27.9M | Sell |
|
|||||
|
2014
Q2 | $29.2M | Buy |
|
|||||
|
2014
Q1 | $26.1M | Sell |
|
|||||
|
2013
Q4 | $23M | Sell |
|
|||||
|
2013
Q3 | $21.5M | Sell |
|
|||||
|
2013
Q2 | $19.6M | Buy |
|